Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Raphael J Landovitz"'
Autor:
Thomas W Gaither, John T Sigalos, Raphael J Landovitz, Jesse N Mills, Mark S Litwin, Sriram V Eleswarapu
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 9, p e38244 (2022)
BackgroundGeosocial networking (GSN) apps play a pivotal role in catalyzing sexual partnering, especially among men who have sex with men. ObjectiveTo quantify the prevalence and disparities in disclosure of pre-exposure prophylaxis (PrEP) use and C
Externí odkaz:
https://doaj.org/article/5632a7f061ed4f0f93cb24bdc373c0e6
Autor:
Oluwadamilola Jolayemi, Laura M Bogart, Erik D Storholm, David Goodman-Meza, Elena Rosenberg-Carlson, Rebecca Cohen, Uyen Kao, Steve Shoptaw, Raphael J Landovitz
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0262926 (2022)
Long-acting injectable (LAI) antiretroviral therapy (ART) is a novel HIV treatment option for people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in the United States in January 2021. In February 2020, we collect
Externí odkaz:
https://doaj.org/article/0ba53f65482042a182e0c20cbd5c8ffa
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0236032 (2020)
BackgroundWe analyzed the effect of time to initiation of antiretroviral therapy (ART) after diagnosis on the probability of HIV-1 transmission events (HIV-TE) in naïve HIV-1-infected men having sex with men (MSM).SettingMathematical model.MethodsWe
Externí odkaz:
https://doaj.org/article/e52ef300a1ef4bdda1d99715451ddc4f
Autor:
Cheríe S Blair, Omai B Garner, Bettina Pedone, Sam Elias, W Scott Comulada, Raphael J Landovitz
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0226413 (2019)
OBJECTIVE:Given rising incidence of Neisseria gonorrhoeae and Chlamydia trachomatis (GC/CT), development of efficacious screening strategies is critical to interruption of the infection cycle. However, a small proportion of nucleic acid amplification
Externí odkaz:
https://doaj.org/article/f88b08eeb169491bb53af3b1f89b2055
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219802 (2019)
BackgroundInitiation of antiretroviral therapy (ART) for HIV infection using regimens that include integrase strand transfer inhibitors (INSTIs) is associated with a faster decline in HIV-1 RNA than what is observed with regimens that are anchored by
Externí odkaz:
https://doaj.org/article/00e19935c1e44919883040b7286daed4
Autor:
Raphael J Landovitz, Sue Li, Beatriz Grinsztejn, Halima Dawood, Albert Y Liu, Manya Magnus, Mina C Hosseinipour, Ravindre Panchia, Leslie Cottle, Gordon Chau, Paul Richardson, Mark A Marzinke, Craig W Hendrix, Susan H Eshleman, Yinfeng Zhang, Elizabeth Tolley, Jeremy Sugarman, Ryan Kofron, Adeola Adeyeye, David Burns, Alex R Rinehart, David Margolis, William R Spreen, Myron S Cohen, Marybeth McCauley, Joseph J Eron
Publikováno v:
PLoS Medicine, Vol 15, Iss 11, p e1002690 (2018)
BACKGROUND:Cabotegravir (CAB) is a novel strand-transfer integrase inhibitor being developed for HIV treatment and prevention. CAB is formulated both as an immediate-release oral tablet for daily administration and as a long-acting injectable suspens
Externí odkaz:
https://doaj.org/article/830d37bc7c0d4f32b2594bc89a7448f5
Autor:
Shashi N Kapadia, Chunyuan Wu, Kenneth H Mayer, Timothy J Wilkin, K Rivet Amico, Raphael J Landovitz, Adriana Andrade, Ying Q Chen, Wairimu Chege, Marybeth McCauley, Roy M Gulick, Bruce R Schackman
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0206577 (2018)
IntroductionTenofovir (TDF)-containing PrEP is effective for HIV prevention, but its effect on health-related quality of life (QOL) is unknown. Using data from HPTN 069/ACTG A5305, a randomized study of potential PrEP regimens comparing maraviroc alo
Externí odkaz:
https://doaj.org/article/ddc445f3d6e34e8ebfae890f8d028c6e
Autor:
Jessica M. Fogel, Estelle Piwowar-Manning, Amber Moser, Tinia Hill, Shahnaz Ahmed, Vanessa Cummings, Heba H. Mostafa, Zhe Wang, Andrea Jennings, Jorge A. Gallardo-Cartagena, María Inés Figueroa, Marty St Clair, Alex R. Rinehart, Adeola Adeyeye, James F. Rooney, Myron S. Cohen, Beatriz Grinsztejn, Raphael J. Landovitz, Susan H. Eshleman
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 8 (2024)
ABSTRACT Detection of HIV infection may be challenging in persons using long-acting cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) due to viral suppression and reduced/delayed antibody production. We evaluated two point-of-care tests for detec
Externí odkaz:
https://doaj.org/article/0ec30651f1934244afc8909a571ed9c4
Autor:
Jenna Yager, Kristina M. Brooks, Jennifer Brothers, Kathleen Mulligan, Raphael J. Landovitz, Daniel Reirden, Meenakshi Malhotra, Carrie Glenny, Paul Harding, Tina Powell, Peter L. Anderson, Sybil Hosek
Publikováno v:
AIDS Research and Human Retroviruses. 38:939-943
Transgender persons have an increased vulnerability to HIV infection yet have not been well-represented in past clinical trials for pre-exposure prophylaxis (PrEP). Because of this, there are few data available to understand whether gender-affirming
Autor:
Raaka Kumbhakar, Moni Neradilek, Ruanne V. Barnabas, Jenell Stewart, Helen C. Stankiewicz Karita, Raphael J. Landovitz, Patricia J. Kissinger, Keith R. Jerome, Michael K. Paasche‐Orlow, Anna Bershteyn, Helen Y. Chu, Kathleen M. Neuzil, Alexander L. Greninger, Alfred Luk, Anna Wald, Elizabeth R. Brown, Christine Johnston
Publikováno v:
Journal of Medical Virology. 94:6091-6096
Two randomized controlled trials demonstrated no clinical benefit of hydroxychloroquine (HCQ) for either postexposure prophylaxis or early treatment of SARS-CoV-2 infection. Using data from these studies, we calculated the time-weighted average chang